Jump to content
Sign in to follow this  
sarara26

Antibody Panel Validation

Recommended Posts

I am switching from an Immucor antibody panel to a Quotient antibody panel and need to do a validation.  Does anyone have any suggestions regarding this? How many samples (both pos and neg) I should use or know of any references I can look at?

Share this post


Link to post
Share on other sites


I would like to know, as well. We're planning to change one regular panel to an enzyme panel and wondering how should the validation be done.

Clarest

Share this post


Link to post
Share on other sites

A validation is not necessary in my opinion.   Would run a few patient samples with current and new panel and results should be comparable or better than the current to be acceptable.  

Share this post


Link to post
Share on other sites
16 hours ago, sarara26 said:

I am switching from an Immucor antibody panel to a Quotient antibody panel and need to do a validation.

My personal opinion - no validation required.

You are switching from one FDA-licensed product to an equivalent. Unless you plan to use it in a fashion contrary to the manufacturer's instructions it's a business decision rather than one of quality or performance.

If you have an internal policy that directs you to "validate" in these situations, you should change that policy. Anything that an end user does to "validate" a commercial, FDA-licensed red cell panel is dwarfed by the process involved to get these products to the market. 

Perhaps more important is that the replacement product suit your facility's specific needs. The typical antigenic make-up of the panel you select should reflect your particular testing requirements. For example....if you have lots of patients with anti- D, a panel with lots of D+ cells my not be very useful.

 

Share this post


Link to post
Share on other sites
14 hours ago, Clarest said:

I would like to know, as well. We're planning to change one regular panel to an enzyme panel and wondering how should the validation be done.

Clarest

Enzyme-treated cells can be very useful in the hands of expert serologists who know the pros and cons of their use. Routine use by front-line techs is probably ill-advised.

In this case, some level of feasibility testing might be useful before switching to an enzyme-treated panel, but I would hesitate to call it "validation". Each facility should determine if such a panel is useful to them, or if it would cause more problems that it would solve.

As I mentioned in earlier in this thread - I believe these are FDA-license reagents and they do not require validation.

Share this post


Link to post
Share on other sites
1 hour ago, exlimey said:

My personal opinion - no validation required.

You are switching from one FDA-licensed product to an equivalent. Unless you plan to use it in a fashion contrary to the manufacturer's instructions it's a business decision rather than one of quality or performance.

If you have an internal policy that directs you to "validate" in these situations, you should change that policy. Anything that an end user does to "validate" a commercial, FDA-licensed red cell panel is dwarfed by the process involved to get these products to the market. 

Perhaps more important is that the replacement product suit your facility's specific needs. The typical antigenic make-up of the panel you select should reflect your particular testing requirements. For example....if you have lots of patients with anti- D, a panel with lots of D+ cells my not be very useful.

 

I can't agree more, with both of your posts.

Share this post


Link to post
Share on other sites
23 hours ago, exlimey said:

Enzyme-treated cells can be very useful in the hands of expert serologists who know the pros and cons of their use. Routine use by front-line techs is probably ill-advised.

In this case, some level of feasibility testing might be useful before switching to an enzyme-treated panel, but I would hesitate to call it "validation". Each facility should determine if such a panel is useful to them, or if it would cause more problems that it would solve.

As I mentioned in earlier in this thread - I believe these are FDA-license reagents and they do not require validation.

Thank you very much exlimey. Really appreciate your input.

Share this post


Link to post
Share on other sites

Thanks for the input everyone.  I guess from a blood banker's mindset everything needs a validation, but in the case of FDA licensed antisera probably not a requirement.

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

  • Similar Content

    • By maureen320
      Hello All,
      Now that Cerner has migrated from major release upgrades to incremental upgrades, how are you managing the Blood Bank validation effort?
      We have not yet received any guidance from Cerner and at this point we feel that we will need to make the determination to validate on our own.
      How are you some of you handling this?
      Thank you!
      Respectfully yours,
      Maureen Slackway, MS, MT(ASCP), CPHIMS, CQA, CAPM
      Senior Application Analyst – Laboratory Systems, Universal Health Services, Inc.
    • By tconnors
      We have 1 antibody panel and the only type of Antibody ID we perform is a modified Antibody ID (1 rule out) for maternal anti-D when we have documentation that the patient received RhIG during the pregnancy.  We have an inspector asking what we do for proficiency for this tsting.  We subscribe to API for our proficiency but they only offer a general ABID proficiency.  Can anyone share how they handle proficiency for this selective type of Antibody ID testing?
    • By SupaLabGrl
      Hello,
      One of our smaller sites uses a specimen rocker to keep platelets agitated before being transfused.  They do not routinely stock platelets which is why purchasing a platelet incubator/agitator is not on the agenda.  On our last accreditation inspection we were cited for not performing a validation of the rocker for platelet storage.  Has anyone done a validation of this type and could you share the details of how to set this up?
      Thanks!
    • By SMILLER
      I have read an article from last year about a lab that routinely runs a gel enzyme panel when they get equivocal results (i.e. antibodies of undetermined significance, AUS's, non-specific reactions) on gel screens or panels.  About 25% of the time they identified significant allo-antibodies that otherwise would have been missed as they would  have been ruled-out on the regular panels.  Does anyone else do this?
      https://academic.oup.com/labmed/article/48/1/24/2666003
      Thanks, Scott
       
    • By Jermin
      Hi All,
      I am about to venture into performing my first ever validation of a test. I have been tasked to validate Rh+K phenotype testing on the BioRad IH-1000 (two of them). We have been, until now, performing the test manually, but as work is getting busier, performing it on the analyser might prove easier (or at least motivate people to perform phenotype). I have been given advise by my senior on how to go about it:
      Select 10 Donor Red Cell units which have Rh+K phenotype performed Perform the phenotype manually Perform the phenotype on the analyser compare the result pat myself on the back, provided I don't mess it up The issue I have is donor red cells doesn't indicate if they are K+, and I wanted some K+ as well as K-. I could always keep testing a lot of donor units until I come across a K+ unit, but I don't want to was a lot of cards (but that might be my last option). If I choose the NBS or BioRad Antibody Panel Cells, then the issue is the strength of the test cells, as they are, I think, 0.8%, and it does not fully represent the way we perform our phenotype manually, as it uses around 5%. I can always try and make the strength of the solution stronger, that is another option. 
      So this is where I am at. If anyone has a suggestion, or better a complete plan, then I am happy to hear it. Also if there is any point I missed or need clarification, please feel free to ask, I'm fixed to this specific thread all night long.
       
      Cheers,
      Jermin
  • Advertisement

  • Site Suggestions

    Site Feedback & Suggestions

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.